Fact CheckerSign in

NCT07433257Recruiting

The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes

The Effect of Local Corticosteroid Injection on Electrophysiological and Ultrasonographic Findings in Carpal Tunnel Syndrome Patients With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 27 May 2026

Brief summary (registry, in English)

Our study was planned as a prospective observational study aiming to compare the post-intervention recovery process between patients with carpal tunnel syndrome (CTS) and diabetes mellitus and patients with idiopathic carpal tunnel syndrome without diabetes mellitus. Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and who were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological findings and who received corticosteroid + local anesthetic injection will be included in the study. Data from patients who meet the inclusion and exclusion criteria will be included in the study. Patients' demographic and clinical data will be recorded. Records will be taken before treatment and at 4 and 12 weeks after treatment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
19 Nov 2025
Start date
1 Mar 2026
Primary completion date
31 Jul 2026
Lead sponsor
Haydarpasa Numune Training and Research Hospital
NCT number
NCT07433257

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 1 Mar 2026 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe carpal tunnel syndrome based on electrophysiological findings
  • Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome
  • Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome
  • Presence of a rheumatological disease
  • History of wrist surgery
  • Less than 6 months since a local corticosteroid injection for carpal tunnel syndrome
  • Less than 3 months since completion of a physical therapy program for carpal tunnel syndrome
  • Infection at the intended injection site
  • Presence of malignancy

Lab values

  • Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%)

Other

  • Pregnancy

Who the study is looking for

  • Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1):
    • Age between 18 and 75 years
    • Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
    • Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
    • Diagnosis of type 2 diabetes mellitus
    • Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7%
  • Idiopathic Carpal Tunnel Syndrome Group (Group 2):
    • Age between 18 and 75 years
    • Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months
    • Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings
    • No diagnosis of diabetes mellitus

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Haydarpasa Numune Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.